• Something wrong with this record ?

Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension

J. Zicha, I. Vaněčková

. 2024 ; 73 (6) : 901-928. [pub] 20241231

Status minimal Language English Country Czech Republic

Document type Journal Article, Review

Sympathetic hyperactivity and relative NO deficiency are characteristic alterations in both genetic and salt hypertension. The contribution of these abnormalities to blood pressure (BP) maintenance can be determined in conscious rats using a consecutive blockade of particular vasoactive systems. Thus, the contribution of pressor effects of angiotensin II to the maintenance of high BP is usually small, but the role of renin-angiotensin system in the development of hypertension mediated by central and peripheral effects of angiotensin II on sympathetic activity is highly important. This is even true in angiotensin-dependent hypertension of heterozygous Ren-2 transgenic rats in which sympathetic hyperactivity is increasing with age. Central sympathoexcitation in this hypertensive model can be inhibited by lower losartan doses than peripheral angiotensin II-dependent vasoconstriction. This experimental model also yielded important knowledge on nephroprotective effects of new therapeutic drugs - endothelin receptor type A blockers. A considerable part of sympathetic vasoconstriction is dependent on the interaction of Ca2+ sensitization (RhoA/Rho kinase pathway) and Ca2+ influx (through L-VDCC). The blockade of these pathways prevents a major part of sympathetic vasoconstriction. Ca2+ sensitization seems to be attenuated in genetic hypertension in order to compensate increased Ca2+ influx. In contrast, enhanced Ca2+ sensitization is a hallmark of salt sensitivity in Dahl rats in which salt hypertension is dependent on increased Ca2+ influx. The attention should also be paid to the impairment of arterial baroreflex sensitivity which permits enhanced BP responses to pressor or depressor stimuli. Some abnormalities can be studied in blood vessels isolated from hypertensive rats but neither conduit arteries nor mesenteric resistance arteries represent the vascular beds decisive for the increased peripheral resistance and high BP. Keywords: Sympathetic vasoconstriction, NO-dependent vasodilatation, Calcium sensitization, Calcium influx, Arterial baroreflex, Spontaneously hypertensive rats, Salt hypertensive Dahl rats, Ren-2 transgenic rats, RAS blockade, SNS blockade, NOS inhibition, Endothelin, Vascular contraction and relaxation, Isolated conduit and resistance arteries, EDCF, PGI2, BKCa channels.

000      
00000naa a2200000 a 4500
001      
bmc25005501
003      
CZ-PrNML
005      
20250312151252.0
007      
ta
008      
250213s2024 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)39903883
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Zicha, J $u Laboratory of Experimental Hypertension, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. josef.zicha@fgu.cas.cz
245    10
$a Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension / $c J. Zicha, I. Vaněčková
520    9_
$a Sympathetic hyperactivity and relative NO deficiency are characteristic alterations in both genetic and salt hypertension. The contribution of these abnormalities to blood pressure (BP) maintenance can be determined in conscious rats using a consecutive blockade of particular vasoactive systems. Thus, the contribution of pressor effects of angiotensin II to the maintenance of high BP is usually small, but the role of renin-angiotensin system in the development of hypertension mediated by central and peripheral effects of angiotensin II on sympathetic activity is highly important. This is even true in angiotensin-dependent hypertension of heterozygous Ren-2 transgenic rats in which sympathetic hyperactivity is increasing with age. Central sympathoexcitation in this hypertensive model can be inhibited by lower losartan doses than peripheral angiotensin II-dependent vasoconstriction. This experimental model also yielded important knowledge on nephroprotective effects of new therapeutic drugs - endothelin receptor type A blockers. A considerable part of sympathetic vasoconstriction is dependent on the interaction of Ca2+ sensitization (RhoA/Rho kinase pathway) and Ca2+ influx (through L-VDCC). The blockade of these pathways prevents a major part of sympathetic vasoconstriction. Ca2+ sensitization seems to be attenuated in genetic hypertension in order to compensate increased Ca2+ influx. In contrast, enhanced Ca2+ sensitization is a hallmark of salt sensitivity in Dahl rats in which salt hypertension is dependent on increased Ca2+ influx. The attention should also be paid to the impairment of arterial baroreflex sensitivity which permits enhanced BP responses to pressor or depressor stimuli. Some abnormalities can be studied in blood vessels isolated from hypertensive rats but neither conduit arteries nor mesenteric resistance arteries represent the vascular beds decisive for the increased peripheral resistance and high BP. Keywords: Sympathetic vasoconstriction, NO-dependent vasodilatation, Calcium sensitization, Calcium influx, Arterial baroreflex, Spontaneously hypertensive rats, Salt hypertensive Dahl rats, Ren-2 transgenic rats, RAS blockade, SNS blockade, NOS inhibition, Endothelin, Vascular contraction and relaxation, Isolated conduit and resistance arteries, EDCF, PGI2, BKCa channels.
650    _2
$a zvířata $7 D000818
650    12
$a hypertenze $x patofyziologie $x metabolismus $7 D006973
650    12
$a vazokonstrikce $x účinky léků $7 D014661
650    _2
$a vazodilatace $x účinky léků $x fyziologie $7 D014664
650    _2
$a lidé $7 D006801
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a sympatický nervový systém $x patofyziologie $x účinky léků $7 D013564
650    _2
$a krevní tlak $x účinky léků $x fyziologie $7 D001794
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a renin-angiotensin systém $x účinky léků $x fyziologie $7 D012084
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vaněčková, I
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 6 (2024), s. 901-928
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39903883 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y - $z 0
990    __
$a 20250213 $b ABA008
991    __
$a 20250312151259 $b ABA008
999    __
$a min $b bmc $g 2283557 $s 1242521
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 73 $c 6 $d 901-928 $e 20241231 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$a Pubmed-20250213

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...